Search results

117 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC Study Advances the Ability to Expose Latent HIV
UNC researchers led by Nancie Archin, PhD, and David Margolis, MD, have shown that interval dosing of the drug Vorinostat reverses HIV latency and is well-tolerated in people living with HIV. However, while Vorinostat makes latent HIV easier to detect, it does not clear or deplete infection, meaning additional advances will be needed to achieve a cure. These results were published in the Journal of Clinical Investigation on July 17.
Located in News / 2017 / July
UNC study will test therapies to eradicate HIV infection—medicine’s holy grail
Researchers from the UNC Institute for Global Health & Infectious Diseases have received $2.7 million from the National Institutes of Health to develop and test new therapeutic agents that may eradicate HIV infection.
Located in Vital Signs / 2009 / Vital Signs - Sept. 11, 2009
UNC study will test therapies to eradicate HIV infection—medicine’s holy grail
Researchers from the UNC Institute for Global Health & Infectious Diseases have received $2.7 million from the National Institutes of Health to develop and test new therapeutic agents that may eradicate HIV infection.
Located in Vital Signs / Archives / Vital Signs - Sept. 11, 2009
UNC study: Maternal, infant antiretrovirals both effective in preventing HIV transmission through breast milk
These findings are important because each year about 200,000 infants worldwide become infected with HIV through breastfeeding, and in the developing world infant formula is both prohibitively expensive and associated with increased infant deaths.
Located in Vital Signs / 2010 / Vital Signs - June 24, 2010
UNC tapped as training center for the state’s HIV health care providers
The University of North Carolina at Chapel Hill School of Medicine has been selected as the new home of the North Carolina AIDS Training and Education Center.
Located in News / 2011 / November
UNC tapped to lead national effort to find a cure for AIDS
Researchers at the University of North Carolina at Chapel Hill have been awarded a $32 million, five-year federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral therapy. Tackling this latent virus is considered key to a cure for AIDS.
Located in News / 2011 / July
UNC to partner in new global HIV/AIDS project
Supporting Operational AIDS Research (SOAR) is a global research project to determine how best to address challenges and gaps that remain in the delivery of HIV and AIDS care and support, treatment, and prevention services.
Located in Vital Signs / 2014 / Oct. 2
UNC to Test Therapeutic Vaccine in People Living with HIV
A multidisciplinary research team at the University of North Carolina at Chapel Hill has been awarded more than $5.6 million from the National Institutes of Health (NIH) to test a therapeutic vaccine in people living with HIV.
Located in Vital Signs / 2017 / July 27
UNC, Duke Team up with Carrboro-based Caktus Group on HIV Gaming App
The Daily Dose app will utilize game mechanics and social networking features to improve adherence to HIV medication.
Located in News / 2013 / October
UNC-led consortium awarded $4 million to train next generation of global health researchers
The consortium, which involves four partnering institutions, will support early-career scientists and clinicians during a yearlong research fellowship at 17 sites in 13 countries in Africa, Asia, and South America.
Located in News / 2012 / October